tiprankstipranks
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
US Market
Want to see ADAPY full AI Analyst Report?

Adaptimmune Therapeutics (ADAPY) Technical Analysis

1,254 Followers

Technical Sentiment

Overall Consensus
Strong Buy
14Bullish
4Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Adaptimmune Therapeutics’s (ADAPY) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Adaptimmune Therapeutics is a Buy.
Adaptimmune Therapeutics’s (ADAPY) 20-Day exponential moving average is 0.04, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 50-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.

Adaptimmune Therapeutics (ADAPY) Pivot Points

Jul 18, 2026, 07:55 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.01
0.02
0.02
0.03
0.04
0.04
0.05
Fibonacci
0.02
0.02
0.02
0.03
0.03
0.04
0.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Adaptimmune Therapeutics (ADAPY) Moving Averages

Jul 18, 2026, 07:55 AM
Period
Simple
Exponential
MA5
0.03Buy
0.03Buy
MA10
0.04Buy
0.04Buy
MA20
0.04Buy
0.04Buy
MA50
0.03Buy
0.03Buy
MA100
0.03Buy
0.03Buy
MA200
0.05Sell
0.06Sell
Adaptimmune Therapeutics’s (ADAPY) 10-Day exponential moving average is 0.04, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) 100-Day exponential moving average is 0.03, while Adaptimmune Therapeutics’s (ADAPY) share price is <$0.1, making it a Buy.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 50-day simple moving average is 0.03, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 100-day simple moving average is 0.03, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAPY) stock price is <$0.1 and Adaptimmune Therapeutics’s (ADAPY) 200-day simple moving average is 0.05, creating a Sell signal.

Adaptimmune Therapeutics (ADAPY) Technical Indicators

Jul 18, 2026, 07:55 AM
Name
Value
Implied Action
RSI (14)
59.75
Neutral
STOCH (9,6)
57.31
Neutral
STOCHRSI (14)
44.44
Neutral
MACD (12,26)
<0.01
Buy
ADX (14)
17.93
Buy
Williams %R
-33.33
Buy
CCI (14)
-50.18
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
70.91
Buy
Bull/Bear Power (13)
-0.01
Sell
Adaptimmune Therapeutics’s (ADAPY) Relative Strength Index (RSI) is 59.75, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAPY) Trend Strength Indicator (ADX) is 17.93, creating a Buy signal.
Adaptimmune Therapeutics’s (ADAPY) Commodity Channel Index (CCI) is -50.18, creating a Neutral signal.

FAQ

Is ADAPY a Buy, Hold, or Sell?
Based on ADAPY’s technical indicators, ADAPY is a Strong Buy.
    What is ADAPY’s RSI (14)?
    ADAPY’s RSI (14) is 59.75, which suggests ADAPY is a Neutral.
      What is ADAPY’s MACD?
      ADAPY’s MACD is <0.01, which suggests ADAPY is a Buy.
        What is ADAPY’s 5-day moving average?
        ADAPY’s 5-day moving average is 0.03, which suggests ADAPY is a Buy.
          What is ADAPY’s 20-day moving average?
          ADAPY 20-day moving average is 0.04, which suggests ADAPY is a Buy.
            What is ADAPY’s 50-day moving average?
            ADAPY’s 50-day moving average is 0.03, which suggests ADAPY is a Buy.
              What is ADAPY’s 200-day moving average?
              ADAPY’s 200-day moving average is 0.05, which suggests ADAPY is a Sell.
                What is ADAPY’s Williams % R (14)?
                ADAPY’s Williams % R (14) is -33.33, which suggests ADAPY is a Buy.
                  What is ADAPY’s CCI (14)?
                  ADAPY’s CCI (14) is -50.18, which suggests ADAPY is a Neutral.